Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.
ACS Chem Neurosci August 1, 2026
Role of β-Arrestin2 Signaling in Neuropharmacological Effects of Psychedelic Drugs.
ACS Chem Neurosci
ISSN 1948-7193
7 papers in the library · 4 citations · publishing 2010-2026
Papers
Correction to "Next-Generation MDMA Analogue SDMA: Pharmacological and Metabolic Insights".
ACS Chem Neurosci March 4, 2026 Nina Kastner, Núria Nadal‐gratacós, Selina Hemmer et al. correction
Correction 1: Table 1.The analyses were conducted using the correct data, and all results, interpretations, and conclusions in the paper remain fully accurate.The issue is limited to the presentation of values in the table.Correction 2: p 4733, second paragraph, 1 st sentence.Thigmotaxis was evaluated to assess potential anxiety-like effects induced by the compounds.When comparing the tested...
Psychedelic Modulation of Excitation/Inhibition Balance: A Dual-Phase Neurodevelopmental Model.
ACS Chem Neurosci January 7, 2026 Charalampos L. Kandilakis, Costas Papatheodoropoulos
Psychedelics are a diverse class of psychoactive compounds that profoundly alter perception, cognition, and emotional states. Recently, classical serotonergic agents, such as psilocybin and lysergic acid diethylamide (LSD), along with atypical agents such as methylenedioxymethamphetamine (MDMA, ecstasy) and ibogaine, have attracted renewed attention due to their rapid and sustained clinical...
Simple Analogs of the LSD D-Ring: A Consideration of Structure-Activity Relationships and Their Potential as Therapeutics.
ACS Chem Neurosci November 5, 2025 Steven A. Barker 1 citation
Simple Analogs of the LSD D-Ring: A Consideration of Structure-Activity Relationships and Their Potential as Therapeutics.
Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.
ACS Chem Neurosci September 13, 2025 Emma M. Bonniwell, Rana Alabdali, Joseph J. Hennessey et al. 3 citations
The serotonin 2C receptor (5-HT 2C ) is a G protein-coupled receptor implicated in multiple physiological and psychological processes and has been investigated as a therapeutic target for neuropsychiatric conditions such as obesity, drug abuse, and depression. With renewed interest in serotonergic psychedelics for treating depression, 5-HT 2C may contribute to psychedelic-induced therapeutic...
Expectancy Effects Cannot Be Neglected in MDMA-Assisted Therapy Research.
ACS Chem Neurosci November 15, 2023
ADVERTISEMENT RETURN TO ARTICLES ASAPPREVViewpointNEXTExpectancy Effects Cannot Be Neglected in MDMA-Assisted Therapy ResearchL. Jacob FlamelingL. Jacob FlamelingInstitute of Psychology, Leiden University, Leiden 2333 AK, The NetherlandsMore by L. Jacob Flamelinghttps://orcid.org/0000-0002-1425-1180, Jacob S. AdayJacob S. AdayDepartment of Anesthesiology, University of Michigan, Ann Arbor,...
Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.
ACS Chem Neurosci February 23, 2010
Reduced 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-initiated oxidative DNA damage and neurodegeneration in prostaglandin H synthase-1 knockout mice.